Lehigh Valley Hospital is a hospital in Allentown, Pennsylvania, United States. Lehigh Valley Hospital is the largest hospital in the Lehigh Valley metropolitan region.

There are 981 beds in Lehigh Valley Hospital-Cedar Crest.

During the past decade, Lehigh Valley Hospital-Cedar Crest conducted 181 clinical trials. In the 10-year time frame, 181 clinical trials started and 101 clinical trials were completed, i.e. on average, 55.8% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 68 clinical trials were completed. i.e. 85% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lehigh Valley Hospital-Cedar Crest" #1 sponsor was "National Cancer Institute (NCI)" with 134 trials, followed by "Alliance for Clinical Trials in Oncology" with 35 trials sponsored, "Children's Oncology Group" with 25 trials sponsored, "SWOG Cancer Research Network" with 25 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lehigh Valley Hospital-Cedar Crest" #1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Lehigh Valley Hospital-Cedar Crest" are "Recurrent Breast Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Invasive Breast Carcinoma" (7 trials). Many other conditions were trialed in "Lehigh Valley Hospital-Cedar Crest" in a lesser frequency.

Most popular intervention types in "Lehigh Valley Hospital-Cedar Crest" are "Drug" (207 trials), "Other" (167 trials), "Biological" (111 trials), "Procedure" (74 trials) and "Radiation" (53 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (88 trials), "Quality-of-Life Assessment" (74 trials), "Questionnaire Administration" (50 trials), "Biospecimen Collection" (37 trials) and "Computed Tomography" (36 trials). Other intervention names were less common.

The vast majority of trials in "Lehigh Valley Hospital-Cedar Crest" are 223 trials for "All" genders, 41 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Lehigh Valley Hospital-Cedar Crest". undefined are not yet recruiting, 87 are recruiting, 123 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Lehigh Valley Hospital-Cedar Crest, 8 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Lehigh Valley Hospital-Cedar Crest, 5 "Phase 1" clinical trials were conducted, 117 "Phase 2" clinical trials and 141 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".